Oxycodone Concentration in the Blood After Oral Premedication
NCT03386318 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2022-05-10
Summary
Oxycodone is an opioid frequently given orally as a premedication prior to any kind of surgery. The initial studies are performed on healthy testpersons and is not given in surgery. The investigators want to explore serum concentration over time (5h) and relate this to Visual Analoge Scale (VAS) postoperatively but also to given mg/kg
Conditions
- Oxycontin
Interventions
- DRUG
-
Oxycodone
Serum concentration per hour from 1 to 5 h
Sponsors & Collaborators
-
Sahlgrenska University Hospital
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2020-05-10
- Completion
- 2021-05-01
- FDA Drug
- Yes
Countries
- Sweden
Study Locations
More Related Trials
-
Pharmacokinetics of Fentanyl Following Intravenous and Oral Routes of Administration in Healthy Volunteers
NCT00714558 ·Status: COMPLETED ·Phase: PHASE1
-
The Effects of Patient Features on Opioid Induced End-Tidal CO2
NCT01371903 ·Status: COMPLETED
-
Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient
NCT01482936 ·Status: COMPLETED ·Phase: PHASE1
-
Oxidative Balance in Opioid Therapy
NCT04227223 ·Status: COMPLETED ·Phase: NA
-
Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects
NCT01959204 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
NCT00626600 ·Status: TERMINATED ·Phase: PHASE3
-
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167127 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers
NCT03888651 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics
NCT03425084 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Opioid Analgesia for MAB
NCT03139240 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling
NCT07223450 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetic-Pharmacodynamic Study of Intravenous Oxycodone in Malaysian Population
NCT02728648 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate of the Effects of Opioid Exposure on the Ability of the Diaphragm Muscle
NCT05856136 ·Status: RECRUITING ·Phase: PHASE4
-
Developing a Method to Objectively Measure Opioid Analgesia
NCT03605966 ·Status: ACTIVE_NOT_RECRUITING
-
Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin
NCT05929339 ·Status: COMPLETED ·Phase: PHASE2
-
24-hour Oral Morphine Equivalent Based Opioid Prescribing After Surgery
NCT04043143 ·Status: COMPLETED ·Phase: NA
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of a Pharmaceutical Interview at the Initiation of Opioid Treatment for Acute Non-cancer Pain
NCT07049796 ·Status: COMPLETED
-
Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
NCT03616639 ·Status: TERMINATED ·Phase: PHASE4
-
Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain
NCT05179421 ·Status: COMPLETED ·Phase: PHASE2
-
Opioid Prescribing in the Emergency Department for Sickle Cell Disease
NCT06835335 ·Status: COMPLETED
-
Pharmacokinetics of Nalbuphine Injection
NCT03826316 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients
NCT01160614 ·Status: COMPLETED ·Phase: PHASE1